BO 1236
| Code | Size | Price |
|---|
| TAR-T26882-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
BO-1236 is an antipseudomonal cephalosporin.
CAS:
105358-77-8
Formula:
C26H28N6O9S2
Molecular Weight:
632.66
Purity:
0.98
SMILES:
[H][C@@]12SCC(C[N+]3(C)Cc4cc(O)c(O)cc4C3)=C(N1C(=O)[C@@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)c1csc(N)n1)C([O-])=O
References
1. Nakagawa S, Sanada M, Matsuda K, Hazumi N, Tanaka N. Biological activity of BO-1236, a new antipseudomonal cephalosporin. Antimicrob Agents Chemother. 1987 Jul;31(7):1100-5. PubMed PMID: 3116919; PubMed Central PMCID: PMC174878.
2. Valiant ME, Gilfillan EC, Gadebusch HH, Pelak BA. L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa. J Antibiot (Tokyo). 1989 May;42(5):807-14. PubMed PMID: 2498278.
3. Weissberger BA, Abruzzo GK, Fromtling RA, Gill C, Ponticas S, Valiant ME, Shungu DL, Gadebusch HH. L-658,310, a new injectable cephalosporin. I. In vitro antibacterial properties. J Antibiot (Tokyo). 1989 May;42(5):795-806. PubMed PMID: 2498277.
4. Hashizume T, Sanada M, Nakagawa S, Tanaka N. Comparison of transport pathways of catechol-substituted cephalosporins, BO-1236 and BO-1341, through the outer membrane of Escherichia coli. J Antibiot (Tokyo). 1990 Dec;43(12):1617-20. PubMed PMID: 2276982.